HomeCompareMANVF vs MRK

MANVF vs MRK: Dividend Comparison 2026

MANVF yields 1333.33% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MANVF wins by $241528700.55M in total portfolio value
10 years
MANVF
MANVF
● Live price
1333.33%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$241528700.61M
Annual income
$210,475,860,072,406.56
Full MANVF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MANVF vs MRK

📍 MANVF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMANVFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MANVF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MANVF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MANVF
Annual income on $10K today (after 15% tax)
$113,333.33/yr
After 10yr DRIP, annual income (after tax)
$178,904,481,061,545.56/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MANVF beats the other by $178,904,481,053,217.16/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MANVF + MRK for your $10,000?

MANVF: 50%MRK: 50%
100% MRK50/50100% MANVF
Portfolio after 10yr
$120764350.33M
Annual income
$105,237,930,041,102.34/yr
Blended yield
87.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MANVF
No analyst data
Altman Z
-222.1
Piotroski
1/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MANVF buys
0
MRK buys
0
No recent congressional trades found for MANVF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMANVFMRK
Forward yield1333.33%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$241528700.61M$56.8K
Annual income after 10y$210,475,860,072,406.56$9,798.13
Total dividends collected$239239876.27M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MANVF vs MRK ($10,000, DRIP)

YearMANVF PortfolioMANVF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$144,033$133,333.33$11,206$366.19+$132.8KMANVF
2$1,948,924$1,794,807.89$12,650$502.35+$1.94MMANVF
3$24,782,219$22,696,870.86$14,407$694.19+$24.77MMANVF
4$296,245,945$269,728,970.81$16,585$967.82+$296.23MMANVF
5$3,330,378,004$3,013,394,842.54$19,342$1,363.89+$3330.36MMANVF
6$35,223,684,321$31,660,179,856.69$22,913$1,947.19+$35223.66MMANVF
7$350,636,384,108$312,947,041,885.16$27,662$2,823.89+$350636.36MMANVF
8$3,286,630,500,315$2,911,449,569,318.85$34,159$4,173.35+$3286630.47MMANVF
9$29,021,346,295,663$25,504,651,660,325.88$43,337$6,308.80+$29021346.25MMANVF
10$241,528,700,608,766$210,475,860,072,406.56$56,776$9,798.13+$241528700.55MMANVF

MANVF vs MRK: Complete Analysis 2026

MANVFStock

Manning Ventures Inc. engages in the sourcing and exploration of mineral properties in Canada. It primarily explores for gold, silver, lead, iron ore, zinc, cobalt, uranium, rare earth, and copper deposits. The company holds interest in the Flint Lake gold project, which includes 4 separate unpatented claims covering an area of approximately 1,712 hectares located in Kenora town, northwestern Ontario. It also holds interest in the Lac Simone property, which consists of 63 mineral claims covering an area of approximately 3,287.4 hectares; and the Hope Lake property which includes 68 mineral claims covering an area of approximately 3,584.1 hectares. In addition, the has an option to acquire a 100% interest in the Broken Lake, Heart Lake, and Hydro properties that consist of 180 mineral claims covering an area of 9,501 hectares located in the Province of Quebec; and the Bounty lithium project comprises 144 mineral claims totaling 7,544 hectares. Further, it holds interest in Butterfly Pond property covering an area of 425 hectares, Mount Hogan property which covers an area of 250 hectares, Red Indian Lake property covering an area of 9,300 hectares, and Little Sheep Brook property covering an area of 700 hectares located in Newfoundland, Canada. Manning Ventures Inc. was incorporated in 2018 and is based in Vancouver, Canada.

Full MANVF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MANVF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MANVF vs SCHDMANVF vs JEPIMANVF vs OMANVF vs KOMANVF vs MAINMANVF vs JNJMANVF vs ABBVMANVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.